Abstract
Background/Objectives: The iliopsoas muscle plays an essential role in lumbopelvic and hip anterior stability, which is particularly important in the presence of limited osseous acetabular coverage anteriorly as in hip dysplasia and/or hip micro-instability. The purpose of this systematic review is to (1) describe iliopsoas activation levels during common rehabilitation exercises and (2) provide an evidence-based exercise progression for strengthening the iliopsoas based on electromyography (EMG) studies. Methods: In total, 109 healthy adult participants ranging from ages 20 to 40 were included in nine studies. PubMed, CINAHL, and Embase databases were systematically searched for EMG studies of the psoas, iliacus, or combined iliopsoas during specific exercise. The Modified Downs and Black Checklist was used to perform a risk of bias assessment. PROSPERO guidelines were followed. Results: Nine studies were included. Findings suggest that the iliopsoas is increasingly activated in ranges of hip flexion of 30–60°, particularly with leg lowering/raising exercises. Briefly, >60% MVIC activity of the iliopsoas was reported in the active straight leg raise (ASLR) in ranges around 60° of hip flexion, as well as with supine hip flexion and leg lifts. In total, 40–60% MVIC was found in exercises including the mid-range of the ASLR around 45° of hip flexion and lifting a straight trunk while in a hip flexed position. Conclusions: The findings suggest that exercises in increased hip flexion provide greater activation of the iliopsoas compared to exercises where the trunk is moving on the lower extremity. Iliopsoas activation can be incrementally progressed from closed to open kinetic chain exercises, and eventually to the addition of external loads. The proposed exercise program interprets the results and offers immediate translation into clinical practice.
Keywords: iliopsoas, electromyography, exercise therapy, biofeedback, hip flexor
1. Introduction
Research labs around the world describe the anatomical and physiological importance of the iliacus muscle, comprising the iliacus, psoas major, and psoas minor [1,2]. With the iliacus, psoas major, and psoas minor, the iliopsoas serves as a primary hip flexor, and contributes to hip external rotation as well as trunk lateral flexion [1,2]. It is considered a core muscle due to its attachments, and functions to stabilize the trunk as well as the pelvis [2]. The psoas major has proximal attachments of the transverse processes, intervertebral disks, and vertebral bodies of T5-L5, while the iliacus has proximal attachments from the superior two thirds of the iliac fossa, sacral ala, and ventral lip of the iliac crest [1]. These two muscles combine to become the iliopsoas at levels L5-S2 and then insert onto the lesser trochanter of the femur, creating the iliopsoas tendon [1]. The psoas minor has a proximal attachment at the T12-L1 vertebrae and a distal attachment of the iliopubic eminence [1]. The iliopsoas functions as both a trunk and hip stabilizer due to its anatomical position, where it is in close proximity to the anterior labrum of the hip joint. In addition to functioning as a hip flexor, a study out of Melbourne Australia described that the iliopsoas also acts as an important anterior joint stabilizer by applying posterior compressive forces to the femoral head, reducing extraneous shear force and lowering the risk of labral or capsular injury in cases of micro-instability. They explain that this stabilization can be likened to the role of the rotator cuff in the shoulder [3]. The present systematic review aims to delineate iliopsoas activation levels during common rehabilitation exercises and offer an evidence-based exercise progression for strengthening the iliopsoas based on EMG studies.
Conditions like adult hip dysplasia and hip micro-instability increase reliance on anterior dynamic stabilizers such as the iliopsoas. Adult hip dysplasia, affecting around 5.2% of the population, is characterized by insufficient coverage of the femoral head by the acetabulum [4]. Conversely, hip micro-instability involves increased femoral head movement within the acetabulum, potentially due to joint laxity [5]. While the prevalence of hip micro-instability remains undefined due to challenges in identifying asymptomatic cases, joint hypermobility is considered one contributing factor with an incidence of 18.9% [6]. Moreover, the presence of injury or tears of the acetabular labrum, which provides native joint stability by creating a vacuum seal between the femoral head and acetabulum, can also lead to hypermobility of the hip joint [7]. Evidence indicates that in both conditions, the iliopsoas plays a crucial role in compensating for decreased anterior joint stability, mitigating the risk of injury to surrounding soft tissue structures. In hip dysplasia, the hypertrophy of the iliocapsularis, a muscle that is clinically and radiographically indistinguishable from the iliopsoas, suggests increased utilization of the iliopsoas as an anterior stabilizer compared to healthy individuals [8].
Two other types of populations in which iliopsoas function may be pertinent are populations with a presence of total hip arthroplasty (THA), and more athletic populations during running speeds (i.e., particularly during running speeds exceeding >7 m/s when increasing cadence and stride frequency) [9,10]. Iliopsoas tendinopathy is prevalent post-THA, affecting about 2.2–2.4% patients who underwent the anterior approach [11,12,13]. Mounting evidence has supported the effectiveness of eccentric exercise along with heavy slow resistance when dealing with tendinopathy in assisting with the remodeling of the collagen fibers within the tendon [14]. Isometrics, particularly early on in the treatment of tendonitis, have also been shown to improve symptoms, but in reality, any type of mechanical loading of the tendon should create improvement [15]. This has been extensively researched in both Achilles and patellar tendinopathy, two of the most common tendinopathies, and can be extrapolated and applied to tendinopathies in other areas. Additionally, individuals participating in higher running speeds have been found to grapple with iliopsoas tendinopathy, with case studies showcasing successful rehabilitation through eccentric loading regimens [16]. The significance of iliopsoas strengthening in sprinters is underscored by studies indicating enhanced speed and endurance with strengthened iliopsoas muscles [17]. Apart from high-speed running, strengthening the hip flexor can benefit those in sports such as soccer in order to increase power and velocity when kicking a ball [18].
Finally, the hip flexor muscles are often found to be atrophied in populations with hip joint pathology such as osteoarthritis [19]. This, in turn, leads to deficits in gait and overall function [19]. In fact, this population was shown to be 50% slower in the stair climb test in a study out of the University of Colorado [20]. Thus, an exercise progression targeting the iliopsoas could benefit this demographic. One Australian study utilized magnetic resonance imaging (MRI) to measure the size of the iliopsoas on healthy people and found it to be a valid tool [19]. However, MRI is obviously quite an expensive tool to use. Therefore, the article suggests use of diagnostic ultrasound, which is becoming more readily available to physical therapists, to monitor the size of muscles such as the iliopsoas. This would allow for a more objective measure to rely on to visualize whether a change in muscle hypertrophy truly does occur throughout the application of the clinical exercise progression [19]. Clearly, a streamlined approach to iliopsoas strengthening would prove beneficial and applicable across multiple demographics.
While systematic reviews have extensively delved into methods for strengthening the gluteal muscles (Ebert et al., Moore et al.), the body of research concerning strengthening and activating the anterior hip musculature remains notably limited. In fact, several of the studies included in this review attempted to target core musculature and took EMG measurements of the anterior hip because they were looking for exercises that decrease hip flexor activation [21,22]. Seemingly few studies to date have focused on identifying effective methods on how to increase the activation of the hip flexors. This knowledge gap leaves clinicians, particularly those working with the aforementioned populations, relying on a trial-and-error approach in regard to exercise prescription and muscle specificity of the anterior hip. By gaining insights into which exercises effectively engage the iliopsoas muscle, clinicians can tailor interventions to directly address the muscle’s role as an anterior dynamic stabilizer, rather than employing a generic approach to strengthening the entire anterior hip musculature. For example, when looking to strengthen the gluteus medius muscle, clinicians can look to sources such as Moore, 2020, and Ebert, 2017, to guide them through what may be the best exercises to choose and how to progress them appropriately. Just as the physical therapy field has prioritized specificity in addressing issues related to the posterior aspect of the hip, the anterior aspect warrants equivalent attention to detail and targeted interventions.
As mentioned, the goal of this systematic review is to describe iliopsoas activation levels during rehabilitation exercises commonly used in a clinical setting and present an exercise progression for strengthening the iliopsoas based on EMG studies. While exercises such as the ASLR are commonly used to target the hip flexors, limited research specifies which muscles within the hip flexors are activated and at what phase of the movement. Moreover, no existing exercise progressions address low-level activation exercises through to high-level strengthening exercises for the hip flexors, particularly the iliopsoas. This information will enable clinicians to enhance their practice with specific populations experiencing hip micro-instability and dysplasia through exercise specificity.
2. Materials and Methods
The systematic review follows The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRSIMA) guidelines as suggested in Liberati 2009 and Swartz 2011 An a priori protocol was completed according with PROSPERO guidelines and was registered on the PROSPERO website prior to submission for publication (registration number: CRD42024556236) [23,24].
2.1. Study Identification and Search Strategy
Applicable articles were found by searching PubMed, CINAHL, and EMBASE databases in January 2024. The search strategy was overseen by a medical school librarian who facilitated the correct use of Boolean modifiers and appropriate translation of the search strategy across databases and ensured accuracy of the search based upon the study’s stated purpose. The keywords used were variations and derivatives of “electromyography”, “iliopsoas”, and “exercise therapy”. Figure 1 demonstrates the search strategy utilized for PubMed along with the correlated results. The search strategies used for CINAHL, and EMBASE are shown in Appendix A, Figure A1 and Figure A2. Certain articles that were identified through this process or by reviewing references of the articles that met the inclusion and exclusion criteria were included as well.
Figure 1.
PubMed search strategy.
Additionally, to ensure a comprehensive identification process, hand-selected articles that were identified through the study selection process or by scouring the references of the included articles were also included.
2.2. Eligibility Criteria
The research question used to frame this systematic review outlined in Table 1 was as follows: which hip exercises have the greatest activation of the hip flexor muscles in a healthy population?
Table 1.
Question and study design inclusion and exclusion criteria.
Question Component | Inclusion Criteria | Exclusion Criteria |
---|---|---|
Population | Healthy (no comorbidities, no history of low back/hip pain) | Non-human study, cadaver study, pathological population |
Intervention | E EMG study of the hip flexors | No EMG measurement of iliopsoas specifically |
Comparison | • n/a | • n/a |
Outcome | • n/a | • n/a |
Study Design | • any | • any |
Time | • any | • any |
Note. N/A: indicates information not applicable; EMG: electromyography.
2.3. Study Selection
The search results of the various databases were put together, with duplicates deleted and filtered independently according to the specified inclusion and exclusion criteria by two members of the research team (Author 1: JJ., Author 2: KK.) using a citation manager, Zotero (Corporation of Digital Scholarship), and systematic review software management system, Covidence (Veritas Health Innovation, Melbourne, Australia). Discrepancies in the filtering of the search results were discussed by the two independent reviewers (Author 1: JJ, Author 2: KK). When the reviewers could not come to an agreement over these discrepancies, an a priori identified third member of the research team helped resolved the issue (Author 4: MJ).
2.4. Data Extraction
Data elements of the full-text articles were created based upon the question posed and the purpose of the current study. This included the types of exercises performed within the studies as well as the measurement of muscular activation such as percent of maximum volitional isometric contraction (MVIC), EMG amplitude, or RMS values.
2.5. Summary Measures and Synthesis of Results
The results were synthesized into three different tables, one for each form of EMG measurement: percent MVIC, EMG amplitude, and RMS value. The findings synthesized compare EMG activation of the iliacus, psoas, and iliopsoas with specific exercises. To ensure ease of implementation into clinical practice and ecological application of the results, an exercise progression including both closed-chain isometrics and open-chain exercises will be proposed. This progression was created utilizing a combination of the levels of activation demonstrated through the EMG studies analyzed and clinical expertise. Starting with less irritable movements that involve using the iliopsoas as a stabilizer to exercises where the iliopsoas becomes a primary mover.
2.6. Risk of Bias Assessment
Consistent with the Cochrane Handbook (Higgins 2019), the risk of bias and quality appraisal of the included studies were assessed [25]. The risk of bias assessment (RoB) of included studies was performed using the Modified Downs and Black Checklist for clinical trials. The Modified Downs and Black Checklist assessment was performed by the primary author and an independent research member (Author 1: JJ, Author 4: MJ, respectively), and the assessment outcomes were double-checked by a third member of the research team (Author 3: GL). Any discrepancies identified by the secondary review were clarified by an a priori identified third member of the research team.
3. Results
3.1. Study Selection and Characteristics
The initial aggregate search results identified 1559 unique articles. Of the 137 articles read in full, 9 articles were deemed appropriate for final analysis. Six were cross-sectional studies, two were non-randomized crossover trials, and one was a descriptive laboratory study. A summary of the outcome characteristics is provided in Appendix B. Study characteristics included authors, study type, research question, patient population, methodology, and conclusions. Figure 2 outlines the study selection process in a PRISMA flow diagram and Table 2 describes the characteristics of each selected study in detail.
Figure 2.
The PRISMA flow diagram.
Table 2.
Characteristics of Included Studies.
First Author (Year) | Study Type | Research Question(s)/Hypotheses | Patient Population Specifics | Methodology | Conclusions |
---|---|---|---|---|---|
Andersson, 1997 [26] | Cross- sectional study |
|
|
Measurement tool:
|
|
Hu, 2011 [27] | Non-randomized crossover trial |
|
|
Measurement tool:
|
|
Jiroumaru, 2014 [28] | Cross-sectional study |
|
|
Measurement tool:
|
|
Okubo, 2021 [29] | Cross-sectional study | What is the activation of the hip flexor and abdominal muscles during an ASLR to end-range hip flexion? |
|
Measurement tool:
|
|
Yamane, 2019 [30] | Cross-sectional study |
|
|
Measurement tool:
|
|
Kim, 2016 [31] | Cross-sectional study |
|
|
Measurement tool:
|
|
Andersson, 1995 [32] | Cross-Sectional study |
|
|
Measurement tool:
|
|
Philippon, 2011 [33] | Descriptive laboratory study |
|
|
Measurement tool:
|
|
Sugajima, 1996 [34] | Non-randomized crossover trial |
|
|
Measurement tool:
|
|
Note. ASLR, active straight leg raise; BMI, body mass index; Cm, centimeters; DF, dorsiflexion; EMG, electromyography; Kg, kilograms; IL, iliacus; IP, iliopsoas; M, meters; MVIC, maximum voluntary isometric contraction; PM, psoas major.; s, seconds; SD, standard deviation; SLR, straight leg raise; Y, year.
3.2. Risk of Bias Assessment
The Modified Downs and Black Checklist results for clinical trials are summarized in Table 3. The Modified Downs and Black Checklist assessment results for each individual study are provided in Appendix C. Andersson (1997), Jiroumaru (2014), Kim (2016), and Okubo (2021) received the highest risk of bias with a score of 13 and Philippon (2011) scored 14 on the checklist, which, according to the checklist, qualifies as “poor” (see Table 3) [26,28,29,31,33]. Andersson (1995), Hu (2011), Sugajima (1996) and Yamane (2019) scored 15, which qualifies as “fair” [27,30,32,34]. However, it is important to note that some of the categories where 0 points were given did not apply to the type of studies, such as blinding of the subjects. The lack of blinding in the rehabilitation and physical therapy literature is well documented and the Modified Downs and Black Checklist results in this review further corroborate this limitation (Armijo-Olivo, S. 2017) [35]. Studies that were found to have a “poor” risk of bias assessment were not excluded; however, Table 4 does outline which studies may be more reliable to pull data from and which were interpreted with more caution.
Table 3.
Summary of risk of bias assessment.
Downs and Black Criteria |
Andersson 1997 [26] | Andersson 1995 [32] | Hu 2011 [27] | Jiroumaru 2014 [28] | Kim 2016 [31] | Okubo 2021 [29] | Philippon 2011 [33] | Sugajima 1996 [34] | Yamane 2019 [30] |
---|---|---|---|---|---|---|---|---|---|
1 | |||||||||
2 | |||||||||
3 | |||||||||
4 | |||||||||
5 | |||||||||
6 | |||||||||
7 | |||||||||
8 | |||||||||
9 | |||||||||
10 | |||||||||
11 | |||||||||
12 | |||||||||
13 | |||||||||
14 | |||||||||
15 | |||||||||
16 | |||||||||
17 | |||||||||
18 | |||||||||
19 | |||||||||
20 | |||||||||
21 | |||||||||
22 | |||||||||
23 | |||||||||
24 | |||||||||
25 | |||||||||
26 | |||||||||
27 | |||||||||
* Total | 13 | 15 | 15 | 13 | 13 | 13 | 14 | 15 | 15 |
Note. Red cell indicates that criteria were not met or that we were unable to determine whether or not they were (0 points); green cell indicates that criteria were met (1 point); * total row indicates the aggregate number of points per column (i.e., for each article).
Table 4.
EMG limitations across the nine studies.
First Author (Year) | Methodology | Strengths and Limitations | Interpretation of Analysis |
---|---|---|---|
Andersson (1995) [32] |
|
Limitations:
|
Clinically applicable |
Andersson (1997) [26] |
|
Limitations:
|
Caution with clinical application |
Hu (2011) [27] |
|
Limitations:
|
Clinically applicable |
Jiroumaru (2014) [28] |
|
Limitations: Conclusions within paper cannot be substantiated by the methods used |
Limited clinical applicability |
Kim (2016) [31] |
|
Limitations:
|
Caution with clinical application |
Okubo (2021) [29] |
|
Limitations:
|
Surface EMG data: limited clinical applicability Intramuscular EMG data: clinically applicable |
Philippon (2011) [33] |
|
Strengths:
|
Clinically applicable |
Sugajima (1996) [34] |
|
Limitations:
|
Caution with clinical application |
Yamane (2019) [30] |
|
Limitations:
|
Limited clinical applicability due to unvalidated assumptions that were used to create the conclusion |
Note. EMG, electromyography; Hz, hertz; kHz, kilohertz, µV, microVolts; SLR, straight leg raise.
3.3. Summary Measures and Synthesis of Results
The primary outcome measure assessed the level of activation of the psoas, iliacus, or iliopsoas measured through percent MVIC (Andersson (1997), Okubo (2021), Yamane (2019), and Kim (2016)), amplitude (Sugajima (1996), Hu (2011), Andersson (1995), and Philippon (2011)), or root mean squared of the EMG from the max voluntary contraction (Jiroumaru (2014)) [26,27,28,29,30,31,32,33,34]. Measurements were conducted using either a fine-wire electrode (Andersson (1997), Okubo (2021), Yamane (2019), Sugajima (1996), Hu (2011), Andersson (1995), and (Philippon (2011)) or a surface electrode (Kim (2016) and Jiroumaru (2014)) while performing a specific exercise. Unless otherwise specified throughout the discussion, it can be assumed that fine-wire electrodes were used for the values mentioned (see Appendix D for specifics on which studies used which type of electrodes). Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8 and Figure 9 graphically display the results from each included study.
Figure 3.
Average %MVIC activation of the iliacus. Note. ASLR; active straight leg raise; ABD, abduction; EMG, electromyography; ER, external rotation; MVIC, maximum volitional isometric contraction.
Figure 4.
Average %MVIC Activation of the psoas major. Note. ASLR; active straight leg raise; ABD, abduction; EMG, electromyography; ER, external rotation; MVIC, maximum volitional isometric contraction. Purple bars highlight same exercises measured in different papers, a large difference can be seen despite the exercise being the same.
Figure 5.
Average %MVIC activation of the iliopsoas. Note. ASLR; active straight leg raise; EMG, electromyography; MVIC, maximal volitional isometric contraction.
Figure 6.
Average EMG amplitude of the iliacus. Note. ASLR; active straight leg raise; EMG, electromyography.
Figure 7.
Average EMG amplitude of the psoas major. Note. ASLR; active straight leg raise; EMG, electromyography.
Figure 8.
Average EMG amplitude of the iliopsoas. Note. EMG, electromyograph; ER, external rotation; MVC, maximum volitional contraction.
Figure 9.
Average RMS value of the iliopsoas. Note. RMS, root mean square.
Results consistently showed increased activation of the iliacus, psoas, and iliopsoas during greater ranges of hip flexion, movement of the lower extremities on the trunk, trunk movement on the lower extremities while supported on the ground surface, and with added external resistance. The iliacus and psoas exhibited activation ranging from 44.1 to 65.2% MVIC and 35 to 67.1% MVIC, respectively, during greater degrees of hip flexion (See Figure 3, Figure 4 and Figure 5) [30].
Beginning with the most commonly included exercise, the straight leg raise, the iliacus demonstrated amplitudes of 40 µV and 50 µV without and with weight, respectively [27]. Meanwhile, the psoas showed amplitudes of 6 µV and 10 µV under the same conditions [27]. The highest activation of the ASLR was in 20° of external rotation and 30° of abduction in 60° of hip flexion according to Yamane et al. Amplitude values during a static leg lift at 60° resulted in 59 µV for a unilateral lift and 55 µV for a bilateral lift for the iliacus, compared to 58 µV for a unilateral lift with a comparable amount for the psoas [32]. At 90° of hip flexion in standing, the iliacus had an amplitude of 99 µV whereas the psoas had an amplitude of 85 µV [32]. See Figure 6 and Figure 7 for amplitude values of the iliacus and psoas during these exercises.
In regard to alternative exercises, refer to Figure 3, where the iliacus shows a high %MVIC during hip flexion with a straight trunk and the feet supported down at the ground (80% MVIC), bilateral lower extremity movement on the trunk (86% MVIC), and unilateral leg movement (68% MVIC) [26]. A movement that significantly activated the iliacus, not involving hip or trunk flexion, was maximal straight leg abduction with an amplitude of 56 µV (see Figure 6) [32]. As for the psoas, a notable exercise that activated the muscle significantly was static ipsilateral lateral trunk flexion against gravity, with an amplitude of 54 µV (see Figure 7) [32].
The combined iliopsoas showed substantial activation during supine hip flexion both concentrically (amplitude of 17.5 µV) and eccentrically (amplitude of 14.6 µV) as seen in Figure 8 [33]. It followed previously mentioned activation patterns in side-lying hip abduction (with some hip external rotation in this condition), with an amplitude of 16 µV (see Figure 8) [33]. It also portrayed activation patterns measured through skin electrodes similar to those of the iliacus and psoas individually, with RMS values of 1.1 and 1.05 at 30 and 60° of hip flexion, respectively (see Figure 9) [28].
Finally, all conditions tested with external load demonstrated increased activation, whether through added weight or water immersion. Particularly, the iliopsoas showed an increase in amplitude from 252 µV of amplitude–frequency to 514 µV when performing 60% MVC hip flexion contraction under water (see Figure 8) [34]. Appendix E demonstrates all individual exercises with their respective recorded EMG values.
4. Discussion
The purpose of this systematic review was to determine the amount of iliopsoas activation during common rehabilitation exercises. A secondary goal was to make the results immediately applicable to clinical setting by proposing a structured treatment progression based on the results. Across the nine included studies, methods to determine iliacus, psoas, or iliopsoas activation varied, including both fine-wire electrodes and surface EMG via adhesive electrodes. The muscle EMG was analyzed across a total of 135 exercises, with the most common exercises being the ASLR, sit-ups, and leg lowering. Variations of these and other exercise were also considered with different lower extremity and trunk positions, with and without external loads and with water resistance.
Several conclusions can be drawn from the results of this systematic review, which include the following:
(1) The iliopsoas can be activated in movements that involve stability of the spine and pelvis such as lateral trunk flexion against gravity or side-lying hip abduction. This suggests that the iliopsoas has an active role in lumbopelvic stability, evident through its activation in exercises not directly involving isotonic hip flexion or lateral trunk flexion. This included sitting with an upright trunk, the clamshell and side-lying hip abduction exercise, and resisted knee flexion and extension. Regarding the straight leg raise, the iliacus was largely active ipsilaterally, and quieter contralaterally, while the psoas was equally active both ipsilaterally and contralaterally. This potentially speaks to the psoas acting as more of a trunk stabilizer with this movement while the iliacus serves as the primary hip flexor or ipsilateral pelvic stabilizer.
(2) Moving the lower extremity on the spine (e.g., leg lowering versus moving the spine on the lower extremity with an exercise such as a sit-up) increased the activation of the iliopsoas. This is likely due to the active movement of the hip flexors required with active hip flexion, whereas subjects likely primarily used abdominal core musculature to perform a more classic version of a sit-up.
(3) Moving a longer lever during hip flexion in open-chain exercise (ASLR) will increase activation, particularly of the iliacus when compared to a short lever (supine hip flexion). This follows the principle of longer levers creating increased torque, therefore necessitating higher muscle activation to meet the demands of this increase [28].
(4) In closed-chain supine exercises such as straight spine hip flexion with the feet stabilized, a knee flexion posture resulted in greater activation of the iliopsoas than with the knees straight. This may be due to the hip flexors being at a more optimal biomechanical position to form a strong contraction than when extended such as in the supine position.
(5) Greater hip flexion angles in an ASLR (30–60 degrees) created higher activation levels of the iliopsoas than the 0–30 degree arc of motion. According to Jiroumaru et al., this is because the activation from other muscles such as tensor fascia latae and sartorius decreases in these ranges, and therefore the relative contribution of the iliopsoas increases [28].
(6) Bilateral movements such as bilateral leg lowering will cause increased activation, likely due to the need for increased stability.
(7) Adding resistance to exercises will increase muscle activation of those involved in producing a hip flexion movement.
The seven conclusive statements of the results listed above as well as the EMG results from the different exercises across the included studies were used to translate the results into a clinically friendly exercise progression targeting the iliopsoas. The intent of this review is to fill the gap created by the limited research specifically focused on strengthening of the hip flexors and to offer clinicians an evidence-based progression to follow when strengthening and training the anterior hip. A targeted approach to the iliopsoas can promote not only muscle strength (i.e., peak force output), but also the important ability to stabilize the femoral head while minimizing compensatory activation of muscles such as the tensor fascia latae. The role of stabilization is of particular importance with the aforementioned populations of hip dysplasia and micro-instability, where the iliopsoas plays a crucial role in the overall stability of the anterior joint. There are certainly other clinical patient demographics in which targeted, incremental loading of the iliopsoas would be indicated and who may also benefit from the proposed clinical progression. Such populations include patients seen post-total-hip-arthroplasty, athletic populations requiring rapid hip flexion (i.e., higher-speed running >7 m/s, persons diagnosed with persistent low back pain, coxa saltans (i.e., snapping hip syndrome), those with peripheral nerve injuries involving femoral nerve and/or nerve roots L1-3, and even post-partum individuals or those with pelvic floor dysfunction [36,37,38].
4.1. Risk of Bias
The nine studies included were assessed for risk of bias using the Modified Downs and Black Checklist (see Appendix C). The checklist provides 27 categories that can be responded to with a “yes”, no”, and with the responses “partially” or “unable to determine” for some items. Each “yes” response counts as a point, a point being positive in terms of decreasing the risk of bias, versus 0 points for a “no” response. All of the studies included in this systematic review scored between 13 and 15 points ranging from poor to fair risk of bias based on the checklist. The “no” responses were often under categories that were not relevant for the studies. For example, none of the studies included blinded subjects. With the type of EMG measurement used in the cross-sectional studies in this systematic review, it would have been unrealistic to blind the subjects. Overall, the scores of 13–15 are a small range, and the studies were deemed to have a similar risk of bias.
4.2. Comparison to Other Systematic Reviews
While countless systematic reviews analyze activation through EMG studies of the posterolateral hip, the author is not aware of any that they analyzed extensive data on the anterior hip. The methods in this systematic review mirror those that have been performed on the posterolateral hip (Moore 2020 and Ebert, 2017), including following the PRISMA guidelines, being conducted on homogenous patient populations, searching similar databases, using similar inclusion and exclusion criteria, performing a quality assessment, and using equivalent data extraction and analysis methods [21,22]. Regarding the anterior hip, one review looked at hip muscle activation in subjects with and without symptoms, but only one study looked at the iliacus or iliocapsularis [39]. A separate review looked at the effects of stretching the hip flexors on performance parameters but did not look at hip flexor strengthening [40]. Therefore, comparison to previous results from other similar systematic reviews was not possible, and more research needs to be performed regarding clinical implications of hip flexor strengthening and the utility of EMG within this research.
4.3. EMG Clinical Utility and Application
To ensure accurate interpretation and clinical application of the EMG results, the lead author consulted Dr. Joyce Campbell PT, PhD, EN, KEMG, an expert within the field of EMG and Director of The Electrophysiology Measurement Laboratory at California State University Long Beach. Through this exchange, Dr. Campbell described several key principles and limitations, pulling from her own knowledge and expertise along with information from the seminal Deluca article; these limitations were synthesized with the author of this systematic review below. They are imperative to consider when applying EMG results to clinical practice [41].
Volume Conduction and Motion Artifact: When using skin electrodes, all electrical signals below 400 Hz coming to the skin will be included. All frequencies above 400 Hz are not seen in the EMG signal; therefore, no fast glycolytic motor unit activity will be recorded. It is also impossible to identify the specific muscle(s) of origin (or separate out-motion electrical artifacts). As for the intramuscular electrodes, if the default low-cut filter is 20 Hz, even these will record contaminating cross-talk/volume conduction as muscle EMG. There should be some evidence of selecting a higher low-cut filter and/or repeating analysis with more selective filters to determine if the EMG conclusions would be improved.
Electrode Placement: The exact location of the placement of the electrodes influences the readings. If you are in the part of the muscle with a high concentration of motor units, the recording will reflect this. However, if the electrodes are placed, for example, near a fascial plane, the recording will not be as good. Depth also matters! Fast glycolytic muscle fibers tend to be more superficial, and slow oxidative fibers are deeper, so knowing the depth you are placing the electrode at is important. Furthermore, if the electrodes are taken out an any point, it will be impossible to re-create the same values, as the electrodes will never be in the exact same positioning.
Timing of Sample: The importance of beginning the recording of the sample prior to the subject even beginning the desired movement cannot be understated. This is because, often, the peak EMG happens so quickly (within milliseconds) that if the reading is taken too late, the peak value may actually be missed. It is also vital to begin the reading prior to movement in order to record the actual change in activation from the muscle at rest to the muscle in movement.
Heterogeneity in EMG Methodology: There are large inconsistencies from one study to the next whether we use the bandpass filter, intramuscular versus skin electrodes, reported outcome measurements in %MVIC, amplitude, or RMS of the EMG, electrode placement, and the timing of the sampling. This causes difficulty in comparing the studies and creates a need for extra scrutiny when evaluating the conclusion of each study.
Lack of Signal Normalization: Normalization of the EMG relying on an individual’s maximum effort on the day of testing is vital to compare values between subjects.
Erroneous EMG Extrapolations to Muscle Force: EMG does not predict muscle force production. Essentially, when there is change in velocity within a movement, there is no linear relationship between EMG and force output.
In discussion with Dr. Campbell, it is clear that within the physical therapy research, EMG studies are often misinterpreted, and the profession needs improvement as a whole in terms of the analysis and application of these studies. Refer to Table 4 created in collaboration for more specifics on how these limitations apply to the nine articles included in this review
4.4. Clinical Exercise Progression
The outlined progression in Appendix B with the associated table with figures was based on findings from this review, and we considered them alongside practice-based evidence and the author’s clinical expertise. It is important to note that the progression is meant as a guideline rather than a prescription and that it should be modified as needed for each individual. There is also a need for the progression to be validated in subsequent clinical trials to determine its true efficacy as well as its ecological and external validity.
The first phase begins with the implementation of very-low-level activation exercises that then transition into the second phase, including exercises that use the iliopsoas indirectly as a stabilizer but not as a primary mover. Following this phase, more direct activation of the iliopsoas is involved with the use of short progressing to long lever isometrics. Although the studies included have expressed that the iliopsoas is generally higher in activation in later ranges of hip flexion, the isometric progression in the fourth phase started at 60° and progressed towards 0°. This was the chosen order of the exercises because although there is more activation of the iliopsoas at 60°, and therefore starting there may be counterintuitive, there is less contribution from muscles such as the tensor fascia latae and the sartorius at this larger angle. The subject would then be able to gain the benefits of strengthening at a position where there is less activation of other accessory muscles, and then move into a position where there is a larger co-contraction once the iliopsoas has been strengthened on a more individual basis. The fifth phase begins the isotonic movements with the similar pattern of a short to long lever progression along with the first introduction of external load. Finally, in the sixth and seventh phase, eccentric movement as well as bilateral lower extremity movement is integrated into the progression for the highest level of iliopsoas strength training. While the recommended dosage is included in this progression, it is up to the clinician’s discretion to adjust the exercises and dosage to each individual patient as appropriate. A criterion for progression from each phase is included for the clinician’s reference as well.
4.5. Limitations
A notable limitation of this systematic review is that all studies were performed on healthy subjects, necessitating caution when applying findings to populations with hip pathology. Furthermore, variation in EMG measurement methods and exercise protocols across studies posed challenges in direct comparisons and exercise progression formulation. For example, Okubo (2021) performed an isometric hold at “the top of the straight leg raise” and achieved 35% MVIC activation of the iliopsoas, while Yamane (2019) reached 60.8% MVIC with an isometric hold at 60° of an ASLR [29,30]. The difference can likely be attributed to the methodology of EMG instrumentation and measurement or the setup and execution of the exercise. Due to the fact that any one of the multiple discrepancies that exist across the methods of these two studies (and the other included study) could explain the difference in the resultant EMG, identification of which specific independent variable was responsible for different results was difficult due to confounding variables. Lastly, the process of putting together an exercise progression, based upon the studies included, required practiced-based evidence and clinical expertise from individuals other than the authors. For example, if going solely based on activation levels, some isometric exercises would be put after something such as a weighted open chain exercise. However, concepts such as consideration of the length of the lever being moved as well as the amount of additional torque required by adding external loading were considered. It is also important to note that the EMG studies utilized to create this progression influenced the choice of exercises by giving guidance to which exercises the iliopsoas is most active with, and this does not directly correlate to indications of the force output of the muscle. This review also does not take into account the timing of muscle activation onset, which can be influential on the function of the muscle itself.
5. Conclusions
In conclusion, while research regarding training the iliopsoas is limited, this review provides practitioners with a specific progression to follow based on the existing evidence. The current systematic review cohesively describes the most current literature in regard to iliopsoas activation patterns with specific exercise. Future research should focus on analyzing a larger breadth of rehabilitation exercises regarding iliopsoas strengthening and activation. There should also be further research conducted utilizing populations with diagnoses of hip dysplasia or hip micro-instability to determine whether activation patterns may be different for this population as well as how the stability of the femoral head changes with increased iliopsoas strength and activation.
Several limitations and the misinterpretations of EMG results exist in both the literature and clinical practice to date. To avoid erroneous conclusions and to improve the accuracy of the translational EMG science, it is recommended that future researchers consider ensuring that the best practices are used in their study designs and ensuring the consistency of anatomical electrode placement, proper signal filtering, unanimous use of intramuscular EMG, and control of the practitioner dependent variables that influence EMG results. Moreover, future systematic reviews that seek to provide clinical recommendations of exercise selection and prescription based upon EMG data should be intentional in their inclusion and exclusion criteria to filter primary studies that use surface EMG and/or have fatal limitations in their methodology that would preclude the results from having external validity and applicability to clinical practice.
In hopes of facilitating the immediate application of the current findings into clinical practice and for ease of translatability, the evidence-based progression is proposed. The progression follows the principle of incremental and progressive overload, initiating with low-level activation exercise through static posture and isometrics and progressing to closed-chain exercise, open-chained short lever exercise, and finally long lever open-chain exercise without and with external resistance.
Appendix A. Additional Search Strategies
Figure A1.
CINAHL Search Strategy.
Figure A2.
Embase search strategy.
Appendix B. Iliopsoas Strengthening Progression
Table A1.
Iliopsoas Strengthening Progression.
Phase | Level | Weight Bearing Status | Movement | Exercise | Parameters |
---|---|---|---|---|---|
Activation—Stability Focused | 1 | Non-Weight-Bearing | Static | Sitting with a straight back | 5 × 45 s 3×/Day 7 Days/Week 1 Week |
Sitting in hyperlordosis | |||||
2 | Non-Weight-Bearing | Dynamic | Side-lying traditional clam shell | 3 × 10 each side 1×/Day 1 Week |
|
Dynamic | Side-lying hip abduction | ||||
Static | Seated lateral flexion of the trunk against gravity | 3 × 45 s 1×/Day 1 Week |
|||
3 | Non-Weight-Bearing | Static |
|
5 × 45 s 1×/Day Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B |
|
Single-Limb Support |
|
||||
3+ | Single-Limb Support |
Static |
|
5 × 45 s 3–4 Days/Week Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B |
|
| |||||
Strength | 4 | Non-Weight-Bearing | Static |
|
5 × 45 s 3–4 Days/Week Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C |
| |||||
| |||||
5 | Non-Weight-Bearing | Dynamic |
|
3 × 12 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C |
|
| |||||
| |||||
6 | Non-Weight-Bearing | Dynamic |
|
3 × 8 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C |
|
| |||||
| |||||
7 | Non-Weight-Bearing | Dynamic |
|
3 × 8 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C 1 week Exercise D |
|
| |||||
| |||||
|
Table A2.
Iliopsoas strengthening progression goals and criteria.
Level | Goal | Criteria for Progression |
---|---|---|
1 | Low-level activation |
|
2 | Activation as an indirect stabilizing muscle |
|
3/3+ | Direct higher-level activation of the muscle |
|
4 | Beginning of strength phase—open-chain long lever isometric |
|
5 | Transition into isotonic strengthening |
|
6 | Strengthen in closed-chain isotonic table exercises |
|
7 | Incorporate eccentric movement and bilateral movements for higher intensity strengthening |
|
Table A3.
Iliopsoas Progression Exercise Images.
Exercise | Starting Position | Ending Position |
---|---|---|
Sitting with a straight back |
![]() |
![]() |
Sitting in hyperlordosis |
![]() |
![]() |
Side-lying traditional clam shell |
![]() |
![]() |
Side-lying hip abduction |
![]() |
![]() |
Seated lateral flexion of the trunk against gravity |
![]() |
![]() |
Seated isometric at 90° of hip flexion |
![]() |
![]() |
Standing ipsilateral hip flexion isometric at 30° |
![]() |
![]() |
Standing ipsilateral hip flexion isometric at 60° |
![]() |
![]() |
Standing ipsilateral hip flexion isometric at 90° |
![]() |
![]() |
Straight leg isometric at 60° of hip flexion |
![]() |
![]() |
Straight leg isometric at 30° of hip flexion |
![]() |
![]() |
Straight leg isometric at 0° of hip flexion |
![]() |
![]() |
Supine hip flexion |
![]() |
![]() |
Active straight leg raise |
![]() |
![]() |
Active straight leg raise with weight |
![]() |
![]() |
Trunk flexion with bent knees |
![]() |
![]() |
Hip flexion with straight supported legs |
![]() |
![]() |
Hip flexion with bent supported legs |
![]() |
![]() |
Eccentric leg raise |
![]() |
![]() |
Eccentric leg raise with weight |
![]() |
![]() |
Bilateral leg lift |
![]() |
![]() |
Bilateral leg lift with weight |
![]() |
![]() |
Appendix C. Risk of Bias Tool
Table A4.
Modified Downs and Black Checklist for risk of bias (RoB) assessment of non-randomized clinical trials.
Item | Criteria | Answers |
---|---|---|
Reporting | ||
1 | Is the hypothesis/aim/objective of the study clearly described? | Yes = 1 No = 0 |
2 | Are the main outcomes to be measured clearly described in the Introduction or Methods section? If the main outcomes are first mentioned in the Results section, the question should be answered no. | Yes = 1 No = 0 |
3 |
Are the characteristics of the patients included in the study clearly described? In cohort studies and trials, inclusion and/or exclusion criteria should be given. In case–control studies, a case definition and the source for controls should be given. |
Yes = 1 No = 0 |
4 | Are the interventions of interest clearly described? Treatments and placebo (where relevant) that are to be compared should be clearly described. | Yes = 1 No = 0 |
5 |
Are the distributions of principal confounders in each group of subjects to be compared clearly described? A list of principal confounders is provided. |
Yes = 2 Partially = 1 No = 0 |
6 |
Are the main findings of the study clearly described? Simple outcome data (including denominators and numerators) should be reported for all major findings so that the reader can check the major analyses and conclusions. (This question does not cover statistical tests that are considered below). |
Yes = 1 No = 0 |
7 |
Does the study provide estimates of the random variability in the data for the main outcomes? In non-normally distributed data, the interquartile range of results should be reported. In normally distributed data, the standard error, standard deviation or confidence intervals should be reported. If the distribution of the data are not described, it must be assumed that the estimates used were appropriate and the question should be answered “yes”. |
Yes = 1 No = 0 |
8 |
Have all important adverse events that may be a consequence of the intervention been reported? This should be answered “yes” if the study demonstrates that there was a comprehensive attempt to measure adverse events. (A list of possible adverse events is provided). |
Yes = 1 No = 0 |
9 |
Have the characteristics of patients lost to follow-up been described? This should be answered “yes” where there were no losses to follow-up or where losses to follow-up were so small that findings would be unaffected by their inclusion. This should be answered “no” where a study does not report the number of patients lost to follow-up. |
Yes = 1 No = 0 |
10 | Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? | Yes = 1 No = 0 |
External validity | ||
11 |
Were the subjects asked to participate in the study representative of the entire population from which they were recruited? The study must identify the source population for patients and describe how the patients were selected. Patients would be representative if they comprised the entire source population, an unselected sample of consecutive patients, or a random sample. Random sampling is only feasible where a list of all members of the relevant population exists. Where a study does not report the proportion of the source population from which the patients are derived, the question should be answered as “unable to determine”. |
Yes = 1 No = 0 Unable to determine = 0 |
12 |
Were those subjects who were prepared to participate representative of the entire population from which they were recruited? The proportion of those asked who agreed should be stated. Validation that the sample was representative would include demonstrating that the distribution of the main confounding factors was the same in the study sample and the source population. |
Yes = 1 No = 0 Unable to determine = 0 |
13 |
Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? For the question to be answered “yes”, the study should demonstrate that the intervention was representative of that in use in the source population. The question should be answered “no” if, for example, the intervention was undertaken in a specialist center unrepresentative of the hospitals most of the source population would attend. |
Yes = 1 No = 0 Unable to determine = 0 |
Internal validity—bias | ||
14 |
Was an attempt made to blind study subjects to the intervention they have received? For studies where the patients would have no way of knowing which intervention they received, this should be answered “yes”. |
Yes = 1 No = 0 Unable to determine = 0 |
15 | Was an attempt made to blind those measuring the main outcomes of the intervention? | Yes = 1 No = 0 Unable to determine = 0 |
17 |
In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case–control studies, is the time period between the intervention and outcome the same for cases and controls? Where follow-up was the same for all study patients, the answer should be “yes”. If different lengths of follow-up were adjusted for by, for example, survival analysis, the answer should be “yes”. Studies where differences in follow-up are ignored should be answered “no”. |
Yes = 1 No = 0 Unable to determine = 0 |
18 |
Were the statistical tests used to assess the main outcomes appropriate? The statistical techniques used must be appropriate to the data. For example, nonparametric methods should be used for small sample sizes. Where little statistical analysis has been undertaken but where there is no evidence of bias, the question should be answered “yes”. If the distribution of the data (normal or not) is not described, it must be assumed that the estimates used were appropriate and the question should be answered “yes”. |
Yes = 1 No = 0 Unable to determine = 0 |
19 |
Was compliance with the intervention/s reliable? Where there was noncompliance with the allocated treatment or where there was contamination of one group, the question should be answered “no”. For studies where the effect of any misclassification was likely to bias any association to the null, the question should be answered “yes”. |
Yes = 1 No = 0 Unable to determine = 0 |
20 |
Were the main outcome measures used accurate (valid and reliable)? For studies where the outcome measures are clearly described, the question should be answered “yes”. For studies which refer to other work or that demonstrates the outcome measures are accurate, the question should be answered as “yes”. |
Yes = 1 No = 0 Unable to determine = 0 |
Internal validity—confounding (selection bias) | ||
21 |
Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited from the same population? For example, patients for all comparison groups should be selected from the same hospital. The question should be answered “unable to determine” for cohort and case–control studies where there is no information concerning the source of patients included in the study. |
Yes = 1 No = 0 Unable to determine = 0 |
22 | Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited over the same period of time? For a study that does not specify the time period over which patients were recruited, the question should be answered as “unable to determine”. | Yes = 1 No = 0 Unable to determine = 0 |
23 | Were study subjects randomized to intervention groups? Studies that state that subjects were randomized should be answered “yes” except where the method of randomization would not ensure random allocation. For example, alternate allocation would score “no” because it is predictable. | Yes = 1 No = 0 Unable to determine = 0 |
24 |
Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? All nonrandomized studies should be answered “no”. If assignment was concealed from patients but not from staff, it should be answered “no”. |
Yes = 1 No = 0 Unable to determine = 0 |
25 |
Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? This question should be answered “no” for trials if the main conclusions of the study were based on analyses of treatment rather than intention to treat; the distribution of known confounders in the different treatment groups was not described; or the distribution of known confounders differed between the treatment groups but was not taken into account in the analyses. In non-randomized studies, if the effect of the main confounders was not investigated or confounding was demonstrated but no adjustment was made in the final analyses, the question should be answered as “no”. |
Yes = 1 No = 0 Unable to determine = 0 |
26 |
Were losses of patients to follow-up taken into account? If the numbers of patients lost to follow-up are not reported, the question should be answered as “unable to determine”. If the proportion lost to follow-up was too small to affect the main findings, the question should be answered “yes”. |
Yes = 1 No = 0 Unable to determine = 0 |
Power | ||
27 | Was a power analysis performed? | Yes = 1 No = 0 Unable to determine = 0 |
Appendix D. Electrode Type
Table A5.
Type of electrode used per study.
First Author/Year | Fine-Wire Electrode | Surface Electrode |
---|---|---|
Andersson et al., 1997 [26] | Fine-Wire Iiliacus Bandpass Filter 10–1000 Hz |
|
Okubo et al., 2021 [29] | Fine-Wire Psoas Major | |
Yamane et al., 2019 [30] | Fine-wire Psoas Major and Iliacus | |
Kim et al., 2016 [31] | Surface sensor iliopsoas | |
Sugajima et al., 1996 [34] | Fine-Wire Iliopsoas | |
Hu et al., 2011 [27] | Fine-Wire Iliopsoas Bandpass Filter Between 20 Hz and 1 kHz |
|
Andersson et al., 1995 [32] | Fine-Wire Psoas Major and Iliacus | |
Philippon et al., 2011 [33] | Fine-Wire Iliopsoas | |
Jiroumaru et al., 2014 [28] | Active electrode iliacus |
Note. Hz, hertz; kHz, kilo-hertz.
Appendix E
Table A6.
Individual Exercise Activation Levels of Iliacus in %MVIC.
Exercise | Average %MVIC Activation of Iliacus |
---|---|
Bilateral leg lift | 86 |
Hip flexion bent supported legs | 80 |
Unilateral leg lift | 68 |
Straight leg raise isometric @60° with 20° ER and 30° ABD | 65.2 |
Hip flexion straight supported legs | 60 |
Straight leg raise isometric @60° with 30° ABD | 59 |
Straight leg raise isometric @45° with 30° ABD | 48.9 |
Straight leg raise isometric @60° with 20° ER | 47.6 |
Straight leg raise isometric @45° with 20° ER and 30° ABD | 46.7 |
Straight leg raise isometric @60° | 44.1 |
Straight leg raise isometric @45° with 20° ER | 41.2 |
Straight leg raise isometric @45° | 40.6 |
Straight leg raise isometric @30° | 38.4 |
Straight leg raise isometric @30° with 20° ER and 30° ABD | 36.7 |
Straight leg raise isometric @30° with 20° ER | 35 |
Straight leg raise isometric @30° with 30° ABD | 32.5 |
Incomplete bent unsupported leg task | 29 |
Trunk flexion bent legs | 16.5 |
Note. ABD, abduction; ER, external rotation; MVIC, maximum volitional isometric contraction.
Table A7.
Individual Exercise Activation Levels of Psoas Major in %MVIC.
Exercise | Average %MVIC of Psoas Major |
---|---|
Straight leg raise isometric @60° with 20° ER and 30° ABD | 67.1 |
Straight leg raise isometric @60° | 60.8 |
Straight leg raise isometric @60° with 20° ER | 60.8 |
Straight leg raise isometric @60° with 30° ABD | 54.3 |
Straight leg raise isometric @45° with 20° ER and 30° ABD | 50.3 |
Straight leg raise isometric @45° | 48.8 |
Straight leg raise isometric @45° with 30° ABD | 45.6 |
Straight leg raise isometric @30° with 20° ER | 44.5 |
Straight leg raise isometric @30° with 20° ER and 30° ABD | 41.1 |
Straight leg raise isometric @45° with 20° ER | 37.7 |
Straight leg raise isometric @30° with 30° ABD | 35.9 |
Hold at top straight leg raise | 35 |
Straight leg raise isometric @30° | 34 |
Late concentric straight leg raise | 30 |
Mid concentric straight leg raise | 15 |
Mid eccentric straight leg raise | 15 |
Early concentric straight leg raise | 10 |
Late eccentric straight leg raise | 10 |
Note. ABD, abduction; ER, external rotation; MVIC, maximum volitional isometric contraction.
Table A8.
Individual Exercise Activation Levels of Iliopsoas in %MVIC.
Exercise | Average %MVIC Iliopsoas |
---|---|
Eccentric leg raise | 23.6 |
Straight leg raise | 17.6 |
Eccentric sit up | 15.8 |
Sit up | 13.2 |
Note. ABD, abduction; ER, external rotation; MVIC, maximum volitional isometric contraction.
Table A9.
Individual Exercise Activation Levels of Iliacus in Amplitude.
Exercise | Average EMG Amplitude (µV) of Iliacus |
---|---|
One leg standing and other flexed at the hip ipsilateral @90° | 99 |
One leg standing and other flexed at the hip ipsilateral@60° | 75 |
Static leg lift at 60° ipsilateral | 59 |
Maximal straight leg abduction ipsilateral | 56 |
One leg standing one leg flexed to 90 at the hip and knee ipsilateral | 55 |
Static leg lift at 60° bilateral | 55 |
ASLR ipsilateral with weight | 50 |
One leg standing and other flexed at the hip ipsilateral @30° | 43 |
60° static angle with support and straight legs | 42 |
ASLR ipsilateral | 40 |
Extension max contralateral | 26 |
Hyperlordosis seated | 22 |
Extension 30° contralateral | 16 |
Maximal straight leg abduction contralateral | 16 |
Static lateral flexion to the contralateral side | 16 |
Static lateral flexion to the ipsilateral side against gravity | 16 |
Sitting with a straight back | 4 |
One leg standing and other flexed at the hip contralateral @30° | 1 |
ASLR contralateral | 0 |
ASLR contralateral with weight | 0 |
Standing | 0 |
Standing with trunk flexed 30° at the hip | 0 |
One leg standing and other flexed at the hip ipsilateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @60° | 0 |
One leg standing and other flexed at the hip contralateral @90° | 0 |
One leg standing one leg flexed to 90 at the hip and knee contralateral | 0 |
Extension 30° ipsilateral | 0 |
Extension max ipsilateral | 0 |
Static lateral flexion to the ipsilateral side | 0 |
Note. ASLR, active straight leg raise; EMG, electromyography.
Table A10.
Individual Exercise Activation Levels of Psoas Major in Amplitude.
Exercise | Average EMG Amplitude (µV) of Psoas Major |
---|---|
One leg standing and other flexed at the hip ipsilateral @90° | 85 |
Static leg lift at 60° bilateral | 59 |
Static leg lift at 60° ipsilateral | 58 |
Static lateral flexion to the ipsilateral side against gravity | 54 |
One leg standing and other flexed at the hip ipsilateral @60° | 52 |
60° static angle with support and straight legs | 52 |
Maximal straight leg abduction ipsilateral | 36 |
One leg standing one leg flexed to 90 at the hip and knee ipsilateral | 34 |
One leg standing and other flexed at the hip ipsilateral @30° | 21 |
Hyperlordosis seated | 17 |
Static lateral flexion to the contralateral side | 16 |
ASLR contralateral with weight | 10 |
ASLR ipsilateral with weight | 10 |
Sitting with a straight back | 9 |
ASLR contralateral | 6 |
ASLR ipsilateral | 6 |
Extension 30° contralateral | 4 |
Extension max contralateral | 4 |
Maximal straight leg abduction contralateral | 4 |
One leg standing and other flexed at the hip contralateral @90° | 3 |
Extension max ipsilateral | 2 |
One leg standing and other flexed at the hip contralateral @30° | 1 |
One leg standing and other flexed at the hip contralateral @60° | 1 |
Standing | 0 |
Standing with trunk flexed 30° at the hip | 0 |
One leg standing and other flexed at the hip ipsilateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @0° | 0 |
One leg standing one leg flexed to 90 at the hip and knee contralateral | 0 |
Extension 30° ipsilateral | 0 |
Static lateral flexion to the ipsilateral side | 0 |
Note. ASLR, active straight leg raise; EMG, electromyography.
Table A11.
Individual Exercise Activation Levels of Iliopsoas in Amplitude.
Exercise | Average EMG Amplitude (µV) of Iliopsoas |
---|---|
60% MVC with immersion | 514 |
40% MVC with immersion | 334 |
60% MVC without immersion | 252 |
40% MVC without immersion | 215 |
20% MVC with immersion | 209 |
20% MVC without immersion | 185 |
Supine hip flexion concentric | 17.5 |
Sidelying hip abduction-ER concentric | 16 |
Supine hip flexion eccentric | 14.6 |
Traditional hip clam concentric | 11.9 |
Sidelying hip abduction-ER eccentric | 11.1 |
Traditional hip clam eccentric | 8 |
Sidelying hip abduction-wall concentric | 7.8 |
Hip clam-neutral concentric | 7.8 |
Sidelying hip abduction-wall eccentric | 6.3 |
Hip clam-neutral eccentric | 4.8 |
Resisted hip extension concentric | 4.4 |
Resisted knee flexion concentric | 4.1 |
Resisted hip extension eccentric | 3.9 |
Resisted knee extension concentric | 3.8 |
Resisted knee flexion eccentric | 3.7 |
Sidelying hip abduction concentric | 3.6 |
Stool hip rotations eccentric | 3.5 |
Resisted knee extension concentric | 3.5 |
Stool hip rotations concentric | 3.4 |
Sidelying hip abduction eccentric | 3.3 |
Double-leg bridge concentric | 3 |
Double-leg bridge eccentric | 2.7 |
Single leg bridge concentric | 2.5 |
Prone heel squeeze concentric | 2.3 |
Single leg bridge eccentric | 2.1 |
Note. ASLR, active straight leg raise; EMG, electromyography; ER, external rotation; MVC, maximum volitional contraction.
Table A12.
Individual Exercise Activation Levels of Iliopsoas in RMS.
Exercise | RMS Value of Iliopsoas |
---|---|
Hip flexion angle @30° | 1.1 |
Hip flexion angle @60° | 1.05 |
Hip flexion angle @0° | 1 |
Hip flexion angle @-10° | 0.9 |
Note. RMS, root mean square.
Author Contributions
Conceptualization, J.J.; methodology, J.J.; formal analysis, J.J. and K.K.; investigation, J.J.; resources, J.J.; writing—original draft preparation, J.J.; writing—review and editing, J.J., M.J. and G.L.; supervision, M.J. and G.L. All authors have read and agreed to the published version of the manuscript.
Data Availability Statement
MDPI is a member of COPE. We fully adhere to its Core Practices and to its Guidelines. MDPI journals uphold a rigorous peer review process together with clear ethical policies and standards to support the addition of high-quality scientific studies to the field of scholarly publication. Where we become aware of ethical issues, we are committed to investigating them and taking necessary action to maintain the integrity of the literature and ensure the safety of research participants.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
There was no funding or financial incentive (including but not limited to salaries, equipment, supplies, and other expenses) for the completion or publication of the current systematic review. The authors of this study report no conflicts of interests based upon financial, non-financial, other professional or personal interests.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Lifshitz L., Bar Sela S., Gal N., Martin R., Fleitman Klar M. Iliopsoas the Hidden Muscle: Anatomy, Diagnosis, and Treatment. Curr. Sports Med. Rep. 2020;19:235–243. doi: 10.1249/JSR.0000000000000723. [DOI] [PubMed] [Google Scholar]
- 2.Tramer J.S., Holmich P., Safran M.R. The Iliopsoas: Anatomy, Clinical Evaluation, and Its Role in Hip Pain in the Athlete: A Scoping Review. J. Am. Acad. Orthop. Surg. 2024;32:e620–e630. doi: 10.5435/JAAOS-D-23-01166. [DOI] [PubMed] [Google Scholar]
- 3.Retchford T.H., Crossley K.M., Grimaldi A., Kemp J.L., Cowan S.M. Can Local Muscles Augment Stability in the Hip? A Narrative Literature Review. J. Musculoskelet. Neuronal Interact. 2013;13:1–12. [PubMed] [Google Scholar]
- 4.Leide R., Bohman A., Wenger D., Overgaard S., Tiderius C.J., Rogmark C. Hip Dysplasia Is Not Uncommon but Frequently Overlooked: A Cross-Sectional Study Based on Radiographic Examination of 1870 Adults. Acta Orthop. 2021;92:575–580. doi: 10.1080/17453674.2021.1936918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dangin A., Tardy N., Wettstein M., May O., Bonin N. Microinstability of the Hip: A Review. Orthop. Traumatol. Surg. Res. 2016;102((Suppl. S8)):S301–S309. doi: 10.1016/j.otsr.2016.09.002. [DOI] [PubMed] [Google Scholar]
- 6.Ejnisman L., Elisman K., Safran M.R. Effectiveness of Nonoperative Management of Hip Microinstability. Am. J. Sports Med. 2022;50:1013–1019. doi: 10.1177/03635465221075349. [DOI] [PubMed] [Google Scholar]
- 7.Bsat S., Frei H., Beaulé P.E. The Acetabular Labrum: A Review of Its Function. Bone Jt. J. 2016;98-B:730–735. doi: 10.1302/0301-620X.98B6.37099. [DOI] [PubMed] [Google Scholar]
- 8.Bolia I., Chahla J., Locks R., Briggs K., Philippon M.J. Microinstability of the Hip: A Previously Unrecognized Pathology. Muscles Ligaments Tendons J. 2016;6:354–360. doi: 10.32098/mltj.03.2016.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dorel S., Guilhem G., Couturier A., Hug F. Adjustment of Muscle Coordination during an All-out Sprint Cycling Task. Med. Sci. Sports Exerc. 2012;44:2154–2164. doi: 10.1249/MSS.0b013e3182625423. [DOI] [PubMed] [Google Scholar]
- 10.Lenhart R.L., Francis C.A., Lenz A.L., Thelen D.G. Empirical Evaluation of Gastrocnemius and Soleus Function during Walking. J. Biomech. 2014;47:2969–2974. doi: 10.1016/j.jbiomech.2014.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Howell M., Rae F.J., Khan A., Holt G. Iliopsoas Pathology after Total Hip Arthroplasty: A Young Person’s Complication. Bone Jt. J. 2021;103-B:305–308. doi: 10.1302/0301-620X.103B2.BJJ-2020-1318.R1. [DOI] [PubMed] [Google Scholar]
- 12.Verhaegen J.C.F., Vandeputte F.-J., Van den Broecke R., Roose S., Driesen R., Timmermans A., Corten K. Risk Factors for Iliopsoas Tendinopathy After Anterior Approach Total Hip Arthroplasty. J. Arthroplast. 2023;38:511–518. doi: 10.1016/j.arth.2022.10.015. [DOI] [PubMed] [Google Scholar]
- 13.Weintraub M.T., Barrack T.N., Burnett R.A., Serino J., Bhanot S.S., Della Valle C.J. Ultrasound-Guided Iliopsoas Bursal Injections for Management of Iliopsoas Bursitis After Total Hip Arthroplasty. J. Arthroplast. 2023;38((Suppl. S2)):S426–S430. doi: 10.1016/j.arth.2022.12.015. [DOI] [PubMed] [Google Scholar]
- 14.Muaidi Q.I. Rehabilitation of Patellar Tendinopathy. J. Musculoskelet. Neuronal Interact. 2020;20:535–540. [PMC free article] [PubMed] [Google Scholar]
- 15.Silbernagel K.G., Hanlon S., Sprague A. Current Clinical Concepts: Conservative Management of Achilles Tendinopathy. J. Athl. Train. 2020;55:438–447. doi: 10.4085/1062-6050-356-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rauseo C. The Rehabilitation of a Runner with Iliopsoas Tendinopathy Using an Eccentric-Biased Exercise—A Case Report. Int. J. Sports Phys. Ther. 2017;12:1150–1162. doi: 10.26603/ijspt20171150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Yamanaka R., Wakasawa S., Yamashiro K., Kodama N., Sato D. Effect of Resistance Training of Psoas Major in Combination with Regular Running Training on Performance in Long-Distance Runners. Int. J. Sports Physiol. Perform. 2021;16:906–909. doi: 10.1123/ijspp.2020-0206. [DOI] [PubMed] [Google Scholar]
- 18.Young W.B., Rath D.A. Enhancing Foot Velocity in Football Kicking: The Role of Strength Training. J. Strength. Cond. Res. 2011;25:561–566. doi: 10.1519/JSC.0b013e3181bf42eb. [DOI] [PubMed] [Google Scholar]
- 19.Mendis M.D., Wilson S.J., Stanton W., Hides J.A. Validity of Real-Time Ultrasound Imaging to Measure Anterior Hip Muscle Size: A Comparison with Magnetic Resonance Imaging. J. Orthop. Sports Phys. Ther. 2010;40:577–581. doi: 10.2519/jospt.2010.3286. [DOI] [PubMed] [Google Scholar]
- 20.Judd D.L., Thomas A.C., Dayton M.R., Stevens-Lapsley J.E. Strength and Functional Deficits in Individuals with Hip Osteoarthritis Compared to Healthy, Older Adults. Disabil. Rehabil. 2014;36:307–312. doi: 10.3109/09638288.2013.790491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ebert J.R., Edwards P.K., Fick D.P., Janes G.C. A Systematic Review of Rehabilitation Exercises to Progressively Load the Gluteus Medius. J. Sport. Rehabil. 2017;26:418–436. doi: 10.1123/jsr.2016-0088. [DOI] [PubMed] [Google Scholar]
- 22.Moore D., Semciw A.I., Pizzari T. A Systematic Review and Meta-Analysis of Common Therapeutic Exercises That Generate Highest Muscle Activity in the Gluteus Medius and Gluteus Minimus Segments. Int. J. Sports Phys. Ther. 2020;15:856–881. doi: 10.26603/ijspt20200856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Swartz M.K. The PRISMA statement: A guideline for systematic reviews and meta-analyses. J. Pediatr. Health Care Off. Publ. Natl. Assoc. Pediatr. Nurse Assoc. Pract. 2011;25:1–2. doi: 10.1016/j.pedhc.2010.09.006. [DOI] [PubMed] [Google Scholar]
- 25.Cumpston M., Li T., Page M.J., Chandler J., Welch V.A., Higgins J.P., Thomas J. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019;10:ED000142. doi: 10.1002/14651858.ED000142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Andersson E.A., Nilsson J., Ma Z., Thorstensson A. Abdominal and Hip Flexor Muscle Activation during Various Training Exercises. Eur. J. Appl. Physiol. Occup. Physiol. 1997;75:115–123. doi: 10.1007/s004210050135. [DOI] [PubMed] [Google Scholar]
- 27.Hu H., Meijer O.G., van Dieën J.H., Hodges P.W., Bruijn S.M., Strijers R.L., Nanayakkara P.W.B., van Royen B.J., Wu W.H., Xia C. Is the Psoas a Hip Flexor in the Active Straight Leg Raise? Eur. Spine J. 2011;20:759–765. doi: 10.1007/s00586-010-1508-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jiroumaru T., Kurihara T., Isaka T. Measurement of Muscle Length-Related Electromyography Activity of the Hip Flexor Muscles to Determine Individual Muscle Contributions to the Hip Flexion Torque. Springerplus. 2014;3:624. doi: 10.1186/2193-1801-3-624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Okubo Y., Kaneoka K., Hasebe K., Matsunaga N., Imai A., Hodges P.W. Differential activation of psoas major and rectus femoris during active straight leg raise to end range. J. Electromyogr. Kinesiol. Off. J. Int. Soc. Electrophysiol. Kinesiol. 2021;60:102588. doi: 10.1016/j.jelekin.2021.102588. [DOI] [PubMed] [Google Scholar]
- 30.Yamane M., Aoki M., Sasaki Y., Kawaji H. Understanding the Muscle Activity Pattern of the Hip Flexors during Straight Leg Raising in Healthy Subjects. Prog. Rehabil. Med. 2019;4:20190007. doi: 10.2490/prm.20190007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kim K., Lee T. Comparison of Muscular Activities in the Abdomen and Lower Limbs While Performing Sit-up and Leg-Raise. J. Phys. Ther. Sci. 2016;28:491–494. doi: 10.1589/jpts.28.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Andersson E., Oddsson L., Grundström H., Thorstensson A. The Role of the Psoas and Iliacus Muscles for Stability and Movement of the Lumbar Spine, Pelvis and Hip. Scand. J. Med. Sci. Sports. 1995;5:10–16. doi: 10.1111/j.1600-0838.1995.tb00004.x. [DOI] [PubMed] [Google Scholar]
- 33.Philippon M.J., Decker M.J., Giphart J.E., Torry M.R., Wahoff M.S., LaPrade R.F. Rehabilitation Exercise Progression for the Gluteus Medius Muscle with Consideration for Iliopsoas Tendinitis: An in Vivo Electromyography Study. Am. J. Sports Med. 2011;39:1777–1785. doi: 10.1177/0363546511406848. [DOI] [PubMed] [Google Scholar]
- 34.Sugajima Y., Mitarai G., Koeda M., Moritani T. Characteristic Changes of Motor Unit Activity in Hip Joint Flexor Muscles during Voluntary Isometric Contraction during Water Immersion. J. Electromyogr. Kinesiol. 1996;6:83–95. doi: 10.1016/1050-6411(95)00020-8. [DOI] [PubMed] [Google Scholar]
- 35.Armijo-Olivo S., Fuentes J., da Costa B.R., Saltaji H., Ha C., Cummings G.G. Blinding in Physical Therapy Trials and Its Association with Treatment Effects: A Meta-epidemiological Study. Am. J. Phys. Med. Rehabil. 2017;96:34–44. doi: 10.1097/PHM.0000000000000521. [DOI] [PubMed] [Google Scholar]
- 36.Zhu Z., Zhang J., Sheng J., Zhang C., Xie Z. Low Back Pain Caused by Iliopsoas Tendinopathy Treated with Ultrasound-Guided Local Injection of Anesthetic and Steroid: A Retrospective Study. J. Pain Res. 2020;13:3023–3029. doi: 10.2147/JPR.S281880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yen Y.-M., Lewis C.L., Kim Y.-J. Understanding and Treating the Snapping Hip. Sports Med. Arthrosc. Rev. 2015;23:194–199. doi: 10.1097/JSA.0000000000000095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mank V.M., Barranco-Trabi J., Mank J.K., Roberts J., Newman D.P. A Case Study of Chronic Iliopsoas Tendinopathy and Sacroiliac Joint Dysfunction Masquerading As Pelvic Girdle Pain. Cureus. 2021;13:e15719. doi: 10.7759/cureus.15719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Stewart C., King M.G., Kemp J.L., Mentiplay B.F., O’Brien M.J., Perraton Z., Lawrenson P.R., Semciw A.I. Hip Muscle Activity in People with Hip-Related Pain Compared to Asymptomatic Controls: A Systematic Review. J. Electromyogr. Kinesiol. 2023;71:102784. doi: 10.1016/j.jelekin.2023.102784. [DOI] [PubMed] [Google Scholar]
- 40.Konrad A., Močnik R., Titze S., Nakamura M., Tilp M. The Influence of Stretching the Hip Flexor Muscles on Performance Parameters. A Systematic Review with Meta-Analysis. Int. J. Environ. Res. Public Health. 2021;18:1936. doi: 10.3390/ijerph18041936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Deluca C. The Use of Surface Electromyography in Biomechanics. J. Appl. Biomech. 1997;13:135–163. doi: 10.1123/jab.13.2.135. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
MDPI is a member of COPE. We fully adhere to its Core Practices and to its Guidelines. MDPI journals uphold a rigorous peer review process together with clear ethical policies and standards to support the addition of high-quality scientific studies to the field of scholarly publication. Where we become aware of ethical issues, we are committed to investigating them and taking necessary action to maintain the integrity of the literature and ensure the safety of research participants.